The age-related attenuation in long-term potentiation is associated with microglial activation

Journal of Neurochemistry

Volumn 99, Issue 4, 2006, Pages 1263-1272

  Griffin, Rebecca ^a   Nally, Rachel ^a   Nolan, Yvonne ^a   McCartney, Yvonne ^a   Linden, James ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Age; Interferon ; Interleukin 1 ; Interleukin 18; Long term potentiation; Microglial activation

Indexed keywords

BIOLOGICAL MARKER; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; MINOCYCLINE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG INHIBITION; HIPPOCAMPUS; INFLAMMATION; LONG TERM POTENTIATION; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD40; ANTIGENS, CD86; BIOLOGICAL MARKERS; CYTOKINES; DENTATE GYRUS; ENCEPHALITIS; GLIOSIS; HIPPOCAMPUS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-1ALPHA; LONG-TERM POTENTIATION; MALE; MEMORY DISORDERS; MICROGLIA; MINOCYCLINE; RATS; RATS, WISTAR;

EID: 33750480549     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04165.x     Document Type: Article

References (51)

1. Avital A., Goshen I., Kamsler A., Segal M., Iverfeldt K., Richter-Levin G. and Yirmiya R. (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13, 826-834.
2. Barry C. E., Nolan Y., Clarke R. M., Lynch A. and Lynch M. A. (2005) Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J. Neurochem. 93, 221-231.
3. Benveniste E. N., Nguyen V. T. and O'Keefe G. M. (2001) Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39, 381-391.
4. Chen M., Ona V. O., Li M. et al. (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6, 797-801.
5. Choi S. H., Lee da Y., Chung E. S., Hong Y. B., Kim S. U. and Jin B. K. (2005) Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J. Neurochem. 95, 1755-1765.
6. Curran B. and O'Connor J. J. (2001) The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108, 83-90.
7. D'Arcangelo G., Grassi F., Ragozzino D., Santoni A., Tancredi V. and Eusebi F. (1991) Interferon inhibits synaptic potentiation in rat hippocampus. Brain Res. 564, 245-248.
8. Davies C. A., Loddick S. A., Toulmond S., Stroemer R. P., Hunt J. and Rothwell N. J. (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19, 87-98.
9. Delgado M. (2003) Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression. J. Biol. Chem. 278, 27 620-27 629.
10. Eckles-Smith K., Clayton D., Bickford P. and Browning M. D. (2000) Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Brain Res. Mol. Brain Res. 78, 154-162.
11. Godbout J. P. and Johnson R. W. (2004) Interleukin-6 in the aging brain. J. Neuroimmunol. 147, 141-144.
12. Hauss-Wegrzyniak B., Vraniak P. and Wenk G. L. (1999) The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiol. Aging 20, 305-313.
13. Kadar T., Silbermann M., Weissman B. A. and Levy A. (1990) Age-related changes in the cholinergic components within the central nervous system. II. Working memory impairment and its relation to hippocampal muscarinic receptors. Mech. Ageing Dev. 55, 139-149.
14. Kim H. S., Whang S. Y., Woo M. S., Park J. S., Kim W. K. and Han I. O. (2004) Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia. J. Neuroimmunol. 151, 85-93.
15. Kim J., Kim C., Kim T. S., Bang S. I., Yang Y., Park H. and Cho D. (2006) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun. 344, 1284-1289.
16. Kullberg S., Aldskogius H. and Ulfhake B. (2001) Microglial activation, emergence of ED1-expressing cells and clusterin upregulation in the aging rat CNS, with special reference to the spinal cord. Brain Res. 899, 169-186.
17. Lee C. K., Weindruch R. and Prolla T. A. (2000) Gene-expression profile of the ageing brain in mice. Nat. Genet. 25, 294-297.
18. Li A. J., Katafuchi T., Oda S., Hori T. and Oomura Y. (1997) Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748, 30-38.
19. Lu T., Pan Y., Kao S. Y., Li C., Kohane I., Chan J. and Yankner B. A. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891.
20. Lynch A. M. and Lynch M. A. (2002) The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur. J. Neurosci. 15, 1779-1788.
21. Lynch M. A. (2004) Long-term potentiation and memory. Physiol. Rev. 84, 87-136.
22. Maher F. O., Nolan Y. and Lynch M. A. (2005) Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol. Aging 26, 717-728.
23. Meda L., Cassatella M. A., Szendrei G. I., Otvos L., Jr, Baron P., Villalba M., Ferrari D. and Rossi F. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
24. Mendoza-Fernandez V., Andrew R. D. and Barajas-Lopez C. (2000) Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res. 885, 14-24.
25. Minogue A. M., Schmid A. W., Fogarty M. P., Moore A. C., Campbell V. A., Herron C. E. and Lynch M. A. (2003) Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? J. Biol. Chem. 278, 27 971-27 980.
26. Mori I., Hossain M. J., Takeda K., Okamura H., Imai Y., Kohsaka S. and Kimura Y. (2001) Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 287, 163-170.
27. Murray C. A. and Lynch M. A. (1998a) Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974-2981.
28. Murray C. A. and Lynch M. A. (1998b) Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J. Biol. Chem. 273, 12 161-12 168.
29. Nolan Y., Maher F. O., Martin D. S., Clarke R. M., Brady M. T., Bolton A. E., Mills K. H. and Lynch M. A. (2005) Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J. Biol. Chem. 280, 9354-9362.
30. O'Donnell E., Vereker E. and Lynch M. A. (2000) Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur. J. Neurosci. 12, 345-352.
31. Okada M., Nakanishi H., Amamoto T., Urae R., Ando S., Yazawa K. and Fujiwara M. (2003) How does prolonged caloric restriction ameliorate age-related impairment of long-term potentiation in the hippocampus? Brain Res. Mol. Brain Res. 111, 175-181.
32. Perry V. H., Matyszak M. K. and Fearn S. (1993) Altered antigen expression of microglia in the aged rodent CNS. Glia 7, 60-67.
33. Popko B., Corbin J. G., Baerwald K. D., Dupree J. and Garcia A. M. (1997) The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14, 19-35.
34. Pugh C. R., Johnson J. D., Martin D., Rudy J. W., Maier S. F. and Watkins L. R. (2000) Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res. 861, 8-15.
35. Raghavendra V., Tanga F. and DeLeo J. A. (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624-630.
36. Rock R. B., Gekker G., Hu S., Sheng W. S., Cheeran M., Lokensgard J. R. and Peterson P. K. (2004) Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17, 942-964.
37. Rozovsky I., Finch C. E. and Morgan T. E. (1998) Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to downregulation. Neurobiol. Aging 19, 97-103.
38. Sanchez Mejia R. O., Ona V. O., Li M. and Friedlander R. M. (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48, 1393-1401.
39. Segovia G., Porras A., Del Arco A. and Mora F. (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech. Ageing Dev. 122, 1-29.
40. Shaw K. N., Commins S. and O'Mara S. M. (2001) Lipopolysaccharide causes deficits in spatial learning in the water maze but not in BDNF expression in the rat dentate gyrus. Behav. Brain Res. 124, 47-54.
41. Sloane J. A., Hollander W., Moss M. B., Rosene D. L. and Abraham C. R. (1999) Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol. Aging 20, 395-405.
42. Song Y., Wei E. Q., Zhang W. P., Ge Q. F., Liu J. R., Wang M. L., Huang X. J., Hu X. and Chen Z. (2006) Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation. Brain Res. 1085, 57-67.
43. Streit W. J., Sammons N. W., Kuhns A. J. and Sparks D. L. (2004) Dystrophic microglia in the aging human brain. Glia 45, 208-212.
44. Sugama S., Wirz S. A., Barr A. M., Conti B., Bartfai T. and Shibasaki T. (2004) Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine treatment. Neuroscience 128, 451-458.
45. Tan J., Town T., Crawford F., Mori T., DelleDonne A., Crescentini R., Obregon D., Flavell R. A. and Mullan M. J. (2002) Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat. Neurosci. 5, 1288-1293.
46. Vereker E., O'Donnell E. and Lynch M. A. (2000) The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20, 6811-6819.
47. Wang Q., Rowan M. J. and Anwyl R. (2004) Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J. Neurosci. 24, 6049-6056.
48. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I. G., Cattaneo E., Ferrante R. J., Kristal B. S. and Friedlander R. M. (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc. Natl Acad. Sci. USA 100, 10 483-10 487.
49. Wesemann D. R., Dong Y., O'Keefe G. M., Nguyen V. T. and Benveniste E. N. (2002) Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages. J. Immunol. 169, 2354-2360.
50. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D. K., Ischiropoulos H. and Przedborski S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771.
51. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T. and Koistinaho J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad. Sci. USA 95, 15 769-15 774.